Concepedia

Christopher S. Lunde

CS

19

Publications

879

Citations

15

H-Index

1995

Active since

Affiliations

University of California, Berkeley(Current)

Theravance Biopharma (United States)

Lawrence Berkeley National Laboratory

Illinois State University

California Institute for Biomedical Research

Christopher S. Lunde is an author at University of California, Berkeley specializing in medicine, drug resistance, and clinical microbiology.

Top concepts

Publications per year

1995–2020

19

Publications

19

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

Christopher S. Lunde, Stephanie R. Hartouni, James W. Janc et al. · Antimicrobial Agents and Chemotherapy · 2009 · 170 citations · Full text

Antimicrobial Activity of the Olive Oil Flavor Compounds

Christopher S. Lunde, Isao Kubo · Journal of Agricultural and Food Chemistry · 1995 · 139 citations

, , +13

Effect of Polygodial on the Mitochondrial ATPase of <i>Saccharomyces cerevisiae</i>

Christopher S. Lunde, Isao Kubo · Antimicrobial Agents and Chemotherapy · 2000 · 108 citations · Full text

In Vitro Antifungal Susceptibilities of Candida albicans and Other Fungal Pathogens to Polygodial, a Sesquiterpene Dialdehyde

Sang Hwa Lee, Jae Ran Lee, Christopher S. Lunde et al. · Planta Medica · 1999 · 68 citations

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani et al. · Nature Communications · 2019 · 59 citations · Full text

Rows per page

1–5 of 19